PRME 241220 2.50P (PRME241220P2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

PRME241220P2500

Watchlist

0.05
-0.05-50.00%

15min DelayClose Nov 25 16:00 ET

0.05High0.05Low

Intraday

5D
Daily

News

Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics
Yahoo FinanceNov 21 04:18 ET
Morgan Stanley Maintains Prime Medicine(PRME.US) With Hold Rating, Maintains Target Price $5
Moomoo NewsNov 15 08:31 ET · Ratings
Prime Medicine, Inc. (PRME) Gets a Hold From Morgan Stanley
TipRanksNov 15 08:17 ET · Ratings
A Quick Look at Today's Ratings for Prime Medicine(PRME.US), With a Forecast Between $7 to $14
Moomoo NewsNov 14 08:00 ET · Ratings
Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans?
Yahoo FinanceNov 14 07:10 ET
Prime Medicine Reports Q3 2024 Financial Progress
TipRanksNov 13 23:06 ET

Comments

Trytosaveabit

Nov 22 19:02

New 13D/A

$Prime Medicine (PRME.US)$ Prime Medicine | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund X, L.P.(11.8%),ARCH Venture Fund X Overage, L.P.(11.8%), etc.
SEC· 17:36

This_Guy

Nov 11 09:59

$Prime Medicine (PRME.US)$ 👀

Jaguar8

Oct 24 07:02

NEWS

$Prime Medicine (PRME.US)$
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Cheok

Sep 30 09:09

$Prime Medicine (PRME.US)$ Break $5!

Jaguar8

Sep 30 08:48

For me this is the biggest news for the day. Great collab with huge milestones

$Prime Medicine (PRME.US)$